| Ident. | Authors (with country if any) | Title |
|---|
| 000019 (2020) |
Martin Michaud [France] ; Florian Catros [France] ; Francis Gaches [France] | Usefulness of serum amyloid a protein dosage for monitoring patients receiving tocilizumab. |
| 000022 (2020) |
Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie] | Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome |
| 000031 (2020) |
Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France] | Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab. |
| 000033 (2020) |
Isaure Vanmeerbeek [Belgique] ; Jenny Sprooten [Belgique] ; Dirk De Ruysscher [Pays-Bas] ; Sabine Tejpar [Belgique] ; Peter Vandenberghe [Belgique] ; Jitka Fucikova [République tchèque] ; Radek Spisek [République tchèque] ; Laurence Zitvogel [France] ; Guido Kroemer [France, République populaire de Chine, Suède] ; Lorenzo Galluzzi [États-Unis, France] ; Abhishek D. Garg [Belgique] | Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology |
| 000053 (2020) |
Jean-Marie Michot [France] ; Laurence Albiges [France] ; Nathalie Chaput [France] ; Veronique Saada [France] ; Fanny Pommeret [France] ; Franck Griscelli [France] ; Corinne Balleyguier [France] ; Benjamin Besse [France] ; Aurélien Marabelle [France] ; Florence Netzer [France] ; Mansouria Merad [France] ; Caroline Robert [France] ; Fabrice Barlesi [France] ; Bertrand Gachot [France] ; Annabelle Stoclin [France] | Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report |
| 000060 (2020) |
Augustin Latourte [France] ; Hang-Korng Ea [France] ; Aline Frazier [France] ; Anne Blanchard [France] ; Frédéric Lioté [France] ; Hubert Marotte [France] ; Thomas Bardin [France] ; Pascal Richette [France] | Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study. |
| 000067 (2020) |
Thomas Maldiney [France] ; Clémence Deschasse [France] ; Philip Bielefeld [France] | Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases. |
| 000072 (2020) |
Rakesh Awasthi [États-Unis] ; Lida Pacaud [États-Unis] ; Edward Waldron [États-Unis] ; Constantine S. Tam [Australie] ; Ulrich J Ger [Autriche] ; Peter Borchmann [Allemagne] ; Samantha Jaglowski [États-Unis] ; Stephen Ronan Foley [Canada] ; Koen Van Besien [États-Unis] ; Nina D. Wagner-Johnston [États-Unis] ; Marie José Kersten [Pays-Bas] ; Stephen J. Schuster [États-Unis] ; Gilles Salles [France] ; Richard T. Maziarz [États-Unis] ; Özlem Anak [États-Unis] ; Christopher Del Corral [États-Unis] ; Jufen Chu [États-Unis] ; Irina Gershgorin [États-Unis] ; Iulian Pruteanu-Malinici [États-Unis] ; Abhijit Chakraborty [États-Unis] ; Karen Thudium Mueller [États-Unis] ; Edmund K. Waller [États-Unis] | Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL |
| 000074 (2020) |
Grégoire Ducoux [France] ; Arthur Guerber [France] ; Cécile-Audrey Durel [France] ; Bouchra Asli [France] ; Jehane Fadlallah [France] ; Arnaud Hot [France] | Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients |
| 000091 (2020) |
Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France] | The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis. |
| 000109 (2020) |
Eric Toussirot [France] | The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition |
| 000111 (2020) |
Charlotte Borocco [France] ; Claire Ballot-Schmit [France] ; Oanez Ackermann [France] ; Nathalie Aladjidi [France] ; Jeremie Delaleu [France] ; Vannina Giacobbi-Milet [France] ; Sarah Jannier [France] ; Eric Jeziorski [France] ; François Maurier [France] ; Yves Perel [France] ; Christophe Piguet [France] ; Eric Oksenhendler [France] ; Isabelle Koné-Paut [France] ; Caroline Galeotti [France] | The French paediatric cohort of Castleman disease: a retrospective report of 23 patients |
| 000139 (2020) |
Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France] | Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study |
| 000159 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
| 000162 (2020) |
Alexandre Sepriano [Oman] ; Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas] | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. |
| 000163 (2020) |
Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France] | Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry. |
| 000188 (2020) |
Milena A. Gianfrancesco [États-Unis] ; Kimme L. Hyrich [Royaume-Uni] ; Laure Gossec [France] ; Anja Strangfeld [Allemagne] ; Loreto Carmona [Espagne] ; Elsa F. Mateus [Portugal, Suisse] ; Paul Sufka [États-Unis] ; Rebecca Grainger [Nouvelle-Zélande] ; Zachary Wallace [États-Unis] ; Suleman Bhana [États-Unis] ; Emily Sirotich [Canada] ; Jean Liew [États-Unis] ; Jonathan S. Hausmann [États-Unis] ; Wendy Costello [Irlande (pays)] ; Philip Robinson [Australie] ; Pedro M. Machado [Royaume-Uni] ; Jinoos Yazdany [États-Unis] | Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries |
| 000209 (2020) |
Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France] | Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab. |
| 000226 (2020) |
Marie Febvre-James [France] ; Valérie Lecureur [France] ; Olivier Fardel [France] | Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes. |
| 000232 (2020) |
Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie] | Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique☆ |
| 000236 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions |
